John Sang Lee - Chief Medical Officer at PhaseBio Pharmaceuticals Inc

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
PHASQ
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by John Sang Lee since 13 Sep 2025

Reported holdings for John Sang Lee in PhaseBio Pharmaceuticals Inc

Form 4 holding Chief Medical Officer

PhaseBio Pharmaceuticals Inc

Security class
Employee Stock Option (right to buy)
Shares / value
115,500
Estimated value
Report date
24 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

PhaseBio Pharmaceuticals Inc

Security class
Restricted Stock Unit
Shares / value
24,750
Estimated value
Report date
24 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for John Sang Lee in PhaseBio Pharmaceuticals Inc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .